Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.

about

Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.

Item

http://www.wikidata.org/entity/Q36362768

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Impact of anticoagulation stra ...... analysis of randomized trials.

@ast

Impact of anticoagulation stra ...... analysis of randomized trials.

@en

type

Item

label

Impact of anticoagulation stra ...... analysis of randomized trials.

@ast

Impact of anticoagulation stra ...... analysis of randomized trials.

@en

prefLabel

Impact of anticoagulation stra ...... analysis of randomized trials.

@ast

Impact of anticoagulation stra ...... analysis of randomized trials.

@en

P1476

Impact of anticoagulation stra ...... -analysis of randomized trials

@en

P2093

Alon Schaffer

http://www.w3.org/2001/XMLSchema#string

Benedetta Bellandi

http://www.w3.org/2001/XMLSchema#string

Giuseppe De Luca

http://www.w3.org/2001/XMLSchema#string

Guido Parodi

http://www.w3.org/2001/XMLSchema#string

Harry Suryapranata

http://www.w3.org/2001/XMLSchema#string

Lucia Barbieri

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intervention: analysis from the national cardiovascular data registry.

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy.

Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI.

Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial.

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.

P304

553-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/CCD.26967

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Monica Verdoia

P577

2017-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28471057

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation